24 studies found for: Lupus AND Los Angeles | Open Studies
Abatacept for SLE Arthritis (IM101-330)
Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry
Nelfinavir in Systemic Lupus Erythematosus
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
|5||Not yet recruiting||
MsciSLE: MSCs in SLE Trial
A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus
A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus
A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.
Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients.
A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)
Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Study to Evaluate BIIB059 in CLE With or Without SLE
Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis
A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)
Rituximab and Belimumab for Lupus Nephritis
Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)
A Study to Evaluate the Safety and Efficacy of Obinutuzumab, an Antibody Targeting Certain Types of Immune Cells, in Participants With Lupus Nephritis (LN)
Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
† Study has passed its completion date and status has not been verified in more than two years.